[关键词]
[摘要]
糖尿病性视网膜病变(diabetic retinopathy，DR)是一种严重的致盲性眼病，糖尿病黄斑水肿(diabetic macular edema，DME)可发生在DR的任一时期，常常引起不易逆转的视力丧失，随着发病机制研究的不断深入，在运用传统激光治疗的同时，新兴的抗炎、抗VEGF药物治疗已取得很大进展，微创技术的革新为手术治疗亦提供更大便利，多种治疗方式的联合应用，也成为治疗的主要趋势。我们对目前DME的主要治疗进展进行综述。
[Key word]
[Abstract]
Diabetic retinopathy(DR),which can cause blindness, is a serious eye diseases. Diabetic macular edema(DME), often causes irreversible vision loss, can occur in any period of DR. The treatment of DME, including laser photocoagulation, anti-inflammatory therapy, anti-VEGF therapy and surgical treatment have made great progress in recent years as the researches on the pathogenesis deepening. The innovation of minimally invasive technique also proved the surgical treatment more convenience. The joint application of a variety of treatments, also become the main trend of treatment. A review of the present status and progress of the treatment was made in this paper.
[中图分类号]
[基金项目]
中国航天科工集团公司2014年医疗卫生科研项目(No.2014-LCYL-006)
